CUZD1 and cancer: For example, the commercial enzyme-linked immunosorbent assay (ELISA) for the pancreatic biomarkers, zona pellucida-like domains protein 1 (CUZD1), has been found to mistakenly recognize CA125, a known cancer antigen, which is nonhomologous to its intended target (53).